Nissui Pharmaceutical Co., Ltd. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Earnings Forecast for the Six Months Ended Ending September 30, 2019; Provides Dividend Forecast for the Second Quarter of Fiscal Year Ending March 31, 2020; Provides Dividend Forecast for Fiscal Year Ending March 31, 2020
The company provides earnings forecast for the Six months ended ending September 30, 2019. The company forecast net sales of ¥6,400 million. Operating profit of ¥430 million. Ordinary profit of ¥470 million. Profit attributable to owners of parent of ¥334 million. Basic earnings per share of ¥14.91.
The company provides earnings forecast for the year ending March 31, 2020. The company forecast net sales of ¥13,300 million. Operating profit of ¥1,330 million. Ordinary profit of ¥1,420 million. Profit attributable to owners of parent of ¥1,014 million. Basic earnings per share of ¥45.28.
The company provides dividend forecast for the Second quarter of fiscal year ending March 31, 2020. For the Second quarter, company forecast dividend of ¥20 per share.
The company provides dividend forecast for Fiscal year ending March 31, 2020. For the fourth quarter, company forecast dividend of ¥20 per share.